![M. Wilsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
M. Wilsey
Presidente presso
SAREPTA THERAPEUTICS, INC.
Patrimonio netto: 5 M $ in data 31/05/2026
Profilo
La dottoressa M. K. Wilsey è presidente di MiMedx Group, Inc., amministratore indipendente di IGM Biosciences, Inc. e presidente di Sarepta Therapeutics, Inc. Fa parte del Consiglio di amministrazione di IGM Biosciences, Inc. La dottoressa Wilsey è stata precedentemente impiegata come direttore indipendente presso Amylin Pharmaceuticals, Inc., presidente e amministratore delegato presso KEW Group, Inc., membro del President's Council of Advisors on Science & Technology, Director-Science, Technology & Economic Policy presso The National Research Council, Managing Director presso RS Investment Management Co. LLC, presidente della National Venture Capital Association, amministratore delegato e socio generale della Robertson Stephens & Co. e cofondatore della Coalition for 21st Century Medicine. Ha anche fatto parte del consiglio di Abgenix, Inc. Si è laureata presso l'Università della California, Davis e ha conseguito un dottorato presso l'Università della California, Davis.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/06/2026 | 224.357 ( 0,21% ) | 4 M $ | 31/05/2026 | |
MIMEDX GROUP, INC. 0,14% | 18/06/2025 | 212.771 ( 0,14% ) | 782 997 $ | 31/05/2026 |
Posizioni attive di M. Wilsey
| Società | Posizione | Inizio |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Presidente | 16/04/2015 |
| MIMEDX GROUP, INC. | Presidente | 19/06/2019 |
Precedenti posizioni note di M. Wilsey
| Società | Posizione | Fine |
|---|---|---|
| IGM BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 14/08/2025 |
Kew, Inc.
 Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Amministratore Delegato | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Direttore/Membro del Consiglio | 08/08/2012 |
RS Investment Management Co. LLC
 RS Investment Management Co. LLC Investment ManagersFinance RS Investments provides investment advice to separately managed accounts and pooled investment vehicles across a range of investment strategies and styles. The firm offers value strategies, growth strategies, emerging markets, and international developed markets. In addition, they oversee the management of various fixed income strategies and a natural resources strategy (offered through the RS mutual funds). Sub-advisers manage the day-to-day investment programs of these strategies. | Corporate Officer/Principal | 01/12/2009 |
President's Council of Advisors on Science & Technology
 President's Council of Advisors on Science & Technology General GovernmentGovernment Provides the Administration services to science and technology | Corporate Officer/Principal | 01/01/2009 |
Formazione di M. Wilsey
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
76
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
RS Investment Management Co. LLC
RS Investment Management Co. LLC Investment ManagersFinance RS Investments provides investment advice to separately managed accounts and pooled investment vehicles across a range of investment strategies and styles. The firm offers value strategies, growth strategies, emerging markets, and international developed markets. In addition, they oversee the management of various fixed income strategies and a natural resources strategy (offered through the RS mutual funds). Sub-advisers manage the day-to-day investment programs of these strategies. | Finance |
Robertson Stephens & Co.
 Robertson Stephens & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
President's Council of Advisors on Science & Technology
President's Council of Advisors on Science & Technology General GovernmentGovernment Provides the Administration services to science and technology | Government |
MiMedx Group, Inc.
 MiMedx Group, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets patent protected regenerative biomaterial products and bioimplants | Health Technology |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
The Coalition for 21st Century Medicine
 The Coalition for 21st Century Medicine Miscellaneous Commercial ServicesCommercial Services The Coalition for 21st Century Medicine's mission is to improve the quality of healthcare by encouraging research, development, and commercialization of innovative diagnostic technologies that will personalize patient care, improve patient outcomes, and substantially reduce healthcare costs. The company is based in Arlington, VA. The company was founded by Howard C. Birndorf, Jeffrey N. Peterson, M. Kathleen Behrens Wilsey, and Patrick F. Terry. | Commercial Services |
Board On Science Technology & Economic Policy | |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
